249 related articles for article (PubMed ID: 35000828)
21. PARa-aOrtic LymphAdenectomy in locally advanced cervical cancer (PAROLA trial): a GINECO, ENGOT, and GCIG study.
Martinez A; Lecuru F; Bizzarri N; Chargari C; Ducassou A; Fagotti A; Fanfani F; Scambia G; Cibula D; Díaz-Feijoo B; Gil Moreno A; Angeles MA; Muallem MZ; Kohler C; Luyckx M; Kridelka F; Rychlik A; Gerestein KG; Heinzelmann V; Ramirez PT; Frumovitz M; Ferron G; Betrian S; Filleron T; Fotopoulou C; Querleu D;
Int J Gynecol Cancer; 2023 Feb; 33(2):293-298. PubMed ID: 36717163
[TBL] [Abstract][Full Text] [Related]
22. Extended field chemoradiation for cervical cancer patients with histologically proven para-aortic lymph node metastases after laparaoscopic lymphadenectomy.
Marnitz S; Schram J; Budach V; Sackerer I; Vercellino GF; Sehouli J; Köhler C
Strahlenther Onkol; 2015 May; 191(5):421-8. PubMed ID: 25413986
[TBL] [Abstract][Full Text] [Related]
23. Significance of para-aortic lymph node evaluation in patients with FIGO IIIC1 cervical cancer.
Cho WK; Kim YJ; Kim H; Kim YS; Park W
Jpn J Clin Oncol; 2020 Sep; 50(10):1150-1156. PubMed ID: 32577748
[TBL] [Abstract][Full Text] [Related]
24. Para-aortic lymph node surgical staging in locally-advanced cervical cancer: comparison between robotic versus conventional laparoscopy.
Loverix L; Salihi RR; Van Nieuwenhuysen E; Concin N; Han S; van Gorp T; Vergote I
Int J Gynecol Cancer; 2020 Apr; 30(4):466-472. PubMed ID: 32079714
[TBL] [Abstract][Full Text] [Related]
25. Residual pelvic lymph node involvement after concomitant chemoradiation for locally advanced cervical cancer.
Houvenaeghel G; Lelievre L; Rigouard AL; Buttarelli M; Jacquemier J; Viens P; Gonzague-Casabianca L
Gynecol Oncol; 2006 Jul; 102(1):74-9. PubMed ID: 16406062
[TBL] [Abstract][Full Text] [Related]
26. Rate of para-aortic lymph node micrometastasis in patients with locally advanced cervical cancer.
Zand B; Euscher ED; Soliman PT; Schmeler KM; Coleman RL; Frumovitz M; Jhingran A; Ramondetta LM; Ramirez PT
Gynecol Oncol; 2010 Dec; 119(3):422-5. PubMed ID: 20837355
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of lymph node dissection on stage IIICr of cervical cancer before CCRT: study protocol for a phase III, randomized controlled clinical trial (CQGOG0103).
He M; Guo M; Zhou Q; Tang Y; Zhong L; Liu Q; Fan X; Zhao X; Zhang X; Chen G; Shen Y; Xu Q; Chen X; Li Y; Zou D
J Gynecol Oncol; 2023 May; 34(3):e55. PubMed ID: 36998225
[TBL] [Abstract][Full Text] [Related]
28. Para-aortic lymph node recurrence after curative radiotherapy for cervical cancer.
Cho WK; Kim YI; Park W; Yang K; Kim H; Cha H
Int J Gynecol Cancer; 2019 Sep; 29(7):1116-1120. PubMed ID: 31474588
[TBL] [Abstract][Full Text] [Related]
29. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era.
Vargo JA; Kim H; Choi S; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Beriwal S
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1091-8. PubMed ID: 25303889
[TBL] [Abstract][Full Text] [Related]
30. Cervical cancer with paraaortic involvement: do patients truly benefit from tailored chemoradiation therapy? A retrospective study on 8 French centers.
Chantalat E; Vidal F; Leguevaque P; Lepage B; Mathevet P; Deslandres M; Motton S
Eur J Obstet Gynecol Reprod Biol; 2015 Oct; 193():118-22. PubMed ID: 26295788
[TBL] [Abstract][Full Text] [Related]
31. Should the Presence of Metastatic Para-Aortic Lymph Nodes in Locally Advanced Cervical Cancer Lead to More Aggressive Treatment Strategies?
Benito V; Carballo S; Silva P; Esparza M; Arencibia O; Federico M; Andújar M; Mori M; Medina N; Lubrano A
J Minim Invasive Gynecol; 2017; 24(4):609-616. PubMed ID: 28161495
[TBL] [Abstract][Full Text] [Related]
32. Toxicity and early clinical outcomes in cervical cancer following extended field helical tomotherapy to para-aortic lymph nodes.
Jouglar E; Thomas L; de la Rochefordière A; Noël G; Le Blanc-Onfroy M; Delpon G; Campion L; Mahé MA
Cancer Radiother; 2016 Dec; 20(8):794-800. PubMed ID: 28270323
[TBL] [Abstract][Full Text] [Related]
33. Retrospective study of pelvic and para-aortic lymph nodes positivity in stage 1A to 2A cervical cancer patients.
John Lim BB; Yong CM
Med J Malaysia; 2021 Jul; 76(4):534-540. PubMed ID: 34305115
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant Radiation Field Extent and Sites of Failure in Node Positive Endometrioid Endometrial Cancer.
Yerramilli D; Chen YH; Venkatachalam V; Alban GM; Buscariollo DL; Cheng T; King MT; Pretz JL; Russo AL; Lee LJ
Pract Radiat Oncol; 2021; 11(5):394-403. PubMed ID: 34015544
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors in locally advanced cervical cancer with pelvic lymph node metastasis.
Pinto PJJ; Chen MJ; Santos Neto E; Faloppa CC; De Brot L; Guimaraes APG; da Costa AABA; Baiocchi G
Int J Gynecol Cancer; 2022 Mar; 32(3):239-245. PubMed ID: 35256409
[TBL] [Abstract][Full Text] [Related]
36. Clinical relevance of addition of conventional treatment to concurrent chemoradiotherapy in patients with FIGO stage III-IV cervical cancer: a retrospective analysis of a Japanese cohort.
Kurosu H; Todo Y; Yamada R; Minowa K; Tsuruta T; Minobe S; Nishiyama N; Kato H
Jpn J Clin Oncol; 2022 Mar; 52(3):244-250. PubMed ID: 34891157
[TBL] [Abstract][Full Text] [Related]
37. Robot-assisted laparoscopic transperitoneal infrarenal lymphadenectomy in patients with locally advanced cervical cancer by single docking: Do we need a backup procedure?
Gucer F; Misirlioglu S; Ceydeli N; Taskiran C
J Robot Surg; 2018 Mar; 12(1):49-58. PubMed ID: 28255734
[TBL] [Abstract][Full Text] [Related]
38. Treatment outcomes of extended-field radiation therapy and the effect of concurrent chemotherapy on uterine cervical cancer with para-aortic lymph node metastasis.
Yoon HI; Cha J; Keum KC; Lee HY; Nam EJ; Kim SW; Kim S; Kim YT; Kim GE; Kim YB
Radiat Oncol; 2015 Jan; 10():18. PubMed ID: 25582425
[TBL] [Abstract][Full Text] [Related]
39. Role of adjuvant therapy in stage IIIC2 endometrial cancer.
Bogani G; Cappuccio S; Casarin J; Narasimhulu DMM; Cilby WA; Glaser GE; Weaver AL; McGree ME; Keeney GL; Weroha J; Petersen IA; Mariani A
Int J Gynecol Cancer; 2020 Aug; 30(8):1169-1176. PubMed ID: 32646864
[TBL] [Abstract][Full Text] [Related]
40. The impact of pre-therapy extraperitoneal surgical staging on the evaluation and treatment of patients with locally advanced cervical cancer.
Odunsi KO; Lele S; Ghamande S; Seago P; Driscoll DL
Eur J Gynaecol Oncol; 2001; 22(5):325-30. PubMed ID: 11766731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
